VUSM alum Crozier relates battle to overcome Ebola

Ian Crozier, M.D., a 1997 graduate of Vanderbilt University School of Medicine, and a former Vanderbilt resident, chief resident and fellow, spent three weeks treating 60 to 80 Ebola patients a day in Kenema, the epicenter of the Ebola epidemic in Sierra Leone.

VU joins national effort to speed Ebola therapy testing

Vanderbilt University researchers have joined a multi-center effort led by Pennsylvania-based Inovio Pharmaceuticals Inc. to accelerate development of potential antibody therapies against the often-lethal Ebola virus.

Studies show human antibodies can fight lethal Marburg virus

Researchers at Vanderbilt University, the University of Texas Medical Branch at Galveston and The Scripps Research Institute for the first time have shown how human antibodies can neutralize the Marburg virus, a close cousin to Ebola.

Vanderbilt trainee on the front line of Ebola outbreak

Rachel Idowu, M.D., MPH, spent five weeks in Africa last summer assisting the Ebola outbreak response in Monrovia, Liberia’s capital and most populous city.

Vanderbilt researchers isolate Ebola-fighting human antibodies for possible treatment

Vanderbilt University researchers have isolated Ebola-fighting human antibodies – the first of their kind – that could lead to a new treatment for the deadly virus.

Vanderbilt continues Ebola virus preparations